We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Infantile Hemangioma in a V2 Distribution: Treatment with Nadolol.
- Authors
Giberson, Mariah; Hayes, Robert
- Abstract
Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers have been favoured over systemic corticosteroids for treatment of disfiguring or life-threatening infantile hemangiomas. We present a case of an 11-week-old female with a 7 week history of an evolving hemangioma along a facial V2 distribution. Physical exam revealed a well-defined bright red plaque over the right zygoma and lower eyelid. MRI, echocardiograph, and liver ultrasound were normal. Patient was treated with nadolol and had a rapid and substantial regression of the hemangioma. Nadolol is an effective treatment option for disfiguring facial infantile hemangioma. The use of beta-blockers as treatment offers clues into the pathogenesis of infantile hemangioma, which is not yet completely understood
- Subjects
TUMORS in infants; NADOLOL; ADRENERGIC beta blockers; PEDIATRICS
- Publication
Journal of Family Medicine & Primary Care, 2015, Vol 4, Issue 1, p135
- ISSN
2249-4863
- Publication type
Case Study
- DOI
10.4103/2249-4863.152272